ELCC 2025 | Dr. Benjamin Besse Discusses De-escalation in Lung Cancer Treatment: How Far Are We From the Goal?

ELCC 2025 | Dr. Benjamin Besse Discusses De-escalation in Lung Cancer Treatment: How Far Are We From the Goal?

At the 2025 European Lung Cancer Conference (ELCC), Professor Benjamin Besse from the Gustave Roussy Institute presented a report titled “Less is More: De-escalation Strategies in Patient Management and Clinical Trials.” He emphasized that while de-escalation strategies for drug treatments are still being actively explored, clinical applications face challenges, such as insufficient research funding.
Professor Aiwen Wu：Should a “Watch and Wait” Approach Be Considered Before Treating Low Rectal Cancer?    | Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee

Professor Aiwen Wu：Should a “Watch and Wait” Approach Be Considered Before Treating Low Rectal Cancer?    | Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee

In the treatment of low rectal cancer, the “watch and wait” strategy has sparked a compelling debate between organ preservation and radical resection. With the advancement of neoadjuvant therapies, some patients achieve clinical complete response (cCR) following chemoradiotherapy, opening the door to non-operative management and the possibility of avoiding a permanent stoma. However, concerns over local regrowth, subjective response assessment, and the psychological burden on patients continue to challenge the broader application of this approach.
JGCA 2025 | Professor Bo Wei: Two Key Future Directions for Neoadjuvant Therapy in Locally Advanced Gastric Cancer—“Precision and Minimally Invasive Approaches”

JGCA 2025 | Professor Bo Wei: Two Key Future Directions for Neoadjuvant Therapy in Locally Advanced Gastric Cancer—“Precision and Minimally Invasive Approaches”

From March 12 to 14, 2025, the 97th Annual Meeting of the Japanese Gastric Cancer Association (JGCA 2025) was held at the Nagoya Congress Center, bringing together leading experts from Japan and across the globe to exchange insights on the latest advancements in gastric cancer prevention and treatment. The event also spotlighted the application and future potential of digital innovations in the field.